Kamunting Street Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
PCM
HI
UOC
ACA
FCM
Kamunting Street Capital Management's HZNP Position: Q3 2023 in Review
Kamunting Street Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 8,562 shares — an estimated $881K sold.
Kamunting Street Capital Management first reported a position in HZNP in Q1 2023 and held it in 2 quarters. The position peaked at $881K in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.
- Kamunting Street Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
- Kamunting Street Capital Management sold 8,562 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $881K.
- Kamunting Street Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 2 quarters.
- Kamunting Street Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $881K in Q2 2023.
- 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.
Based on Kamunting Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.